Similar articles

• The effect of triple therapy on cyclosporine nephrotoxicity and hypertension in renal transplantation.

  Landsberg D, Rae A, Chiu A, Werb R, Taylor P, Chan-Yan C, Manson AD. Landsberg D, et al. Transplant Proc. 1989 Apr;21(2):3323-4. Transplant Proc. 1989. PMID: 2652826 No abstract available.
• The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.

  Landsberg DN, Rae A, Chiu A, Werb R, Taylor P, Chan-Yan C, Manson AD. Landsberg DN, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1550-1. Transplant Proc. 1989. PMID: 2652502 No abstract available.
• Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.

  Kootte AM, van Dorp WT, van Bockel JH, van Es LA, Paul LC. Kootte AM, et al. Transplant Proc. 1989 Feb;21(1 Pt 2):1585-6. Transplant Proc. 1989. PMID: 2652515 Clinical Trial. No abstract available.
• Clinical and experimental studies with cyclosporine in renal transplantation.

  Kahan BD, van Buren CT, Flechner SM, Jarowenko M, Yasumura T, Rogers AJ, Yoshimura N, LeGrue S, Drath D, Kerman RH. Kahan BD, et al. Surgery. 1985 Feb;97(2):125-40. Surgery. 1985. PMID: 3881837 Review. No abstract available.
• Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.

  Vanrenterghem Y, Peeters J. Vanrenterghem Y, et al. Transplant Proc. 1996 Aug;28(4):2097-9. Transplant Proc. 1996. PMID: 8769165 Review. No abstract available.